SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ICOS Corporation
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
1139 66 0 ICOS
Emcee:  Gerald R. Lampton Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
564 I listened to the ICOS conference call from Thursday, October 22. For the mostLel H-10/24/1998
563 V1, The diluted stock calculation assumes you use that $120m in cash to repurcBiomaven-10/3/1998
562 Peter, You are right it is a combination of warrants and options but I don'Vector1-10/3/1998
561 V1, <i>ICOS has 55m shares outstanding and when you include the 15 milliBiomaven-10/2/1998
560 ICOS has 55m shares outstanding and when you include the 15 million in in the Vector1-10/2/1998
559 The exact clinical trial data have not been published or presented, but I expecLel H-10/2/1998
558 Mccament thought this was undervalued when it was at 22-24, that was before thebdusa1-10/1/1998
557 Pfe has 1.3 billion shares of common stock while Icos has 32 million. Big thinMyron David Kor-10/1/1998
556 As an occasional investor in ICOS. I'm still asking myself, what has PFE shJeff Jordan-10/1/1998
555 Lee, I have an order in to buy Icos tomorrow. I have watched this stock all sumjhg_in_kc-10/1/1998
554 She finished strong on good volume. I saw a couple of 100K blocks trade at $18limit-10/1/1998
553 The market is under a tremendous amount of pressure this morning. I don't Lel H-10/1/1998
552 This sounds like the type of deal that I had hoped ICOS would negotiate. It apLel H-10/1/1998
551 Great deal with Lilly. See yahoo wire.bdusa1-10/1/1998
550 <i>Can you list Jim Mcamant's address for purchasing his newsletter?&bluejeans-9/26/1998
549 Rathman bought close to 300,000 shares at around $12 within the past year, so Myron David Kor-9/26/1998
548 How about how long he was with AMGN? I did a terrible job in subject syntax baM. Alexander-9/26/1998
547 I have been following this company since '91, now own to hold. Back then I Patricia Smith-9/26/1998
546 Hello all! New lurker as of 15 minutes here. But I have started off as a one oM. Alexander-9/25/1998
545 For your information I found the following in an excerpt from an article that Jdebra vogt-9/25/1998
544 Lel, Very informative post. Thanks. To longs, remember 8 drugs in pipeline andlimit-9/21/1998
543 The clinical trial results were a mixed bag, to be sure. I would like to see aLel H-9/20/1998
542 I'm pretty sure that the shares mentioned in the September 16 SEC filing arLel H-9/20/1998
541 Interesting that price moved up prior to study release. Always thought prenews bdusa1-9/20/1998
540 Yeah i agree it is risky to place my bet solely on the biotech industry. But iMichael Collins-9/19/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):